Logo image of NXU

NXU INC (NXU) Stock Fundamental Analysis

NASDAQ:NXU - Nasdaq - US62956D2045 - Common Stock

0.56  +0.01 (+1.82%)

After market: 0.5579 0 (-0.38%)

Fundamental Rating

2

NXU gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 119 industry peers in the Specialty Retail industry. Both the profitability and financial health of NXU have multiple concerns. NXU has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NXU has reported negative net income.
In the past year NXU has reported a negative cash flow from operations.
NXU had negative earnings in each of the past 5 years.
NXU had a negative operating cash flow in each of the past 5 years.
NXU Yearly Net Income VS EBIT VS OCF VS FCFNXU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M -100M

1.2 Ratios

NXU has a worse Return On Assets (-94.04%) than 97.41% of its industry peers.
NXU has a worse Return On Equity (-154.17%) than 81.03% of its industry peers.
Industry RankSector Rank
ROA -94.04%
ROE -154.17%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NXU Yearly ROA, ROE, ROICNXU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 -10K -20K -30K

1.3 Margins

NXU's Gross Margin of 78.03% is amongst the best of the industry. NXU outperforms 98.28% of its industry peers.
The Profit Margin and Operating Margin are not available for NXU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NXU Yearly Profit, Operating, Gross MarginsNXU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 -2K -4K -6K -8K

More info and screens

3

2. Health

2.1 Basic Checks

NXU does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for NXU. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NXU Yearly Shares OutstandingNXU Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 5M 10M
NXU Yearly Total Debt VS Total AssetsNXU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

2.2 Solvency

NXU has an Altman-Z score of -19.57. This is a bad value and indicates that NXU is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -19.57, NXU is doing worse than 95.69% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that NXU is not too dependend on debt financing.
NXU has a Debt to Equity ratio of 0.00. This is in the better half of the industry: NXU outperforms 76.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -19.57
ROIC/WACCN/A
WACC8.12%
NXU Yearly LT Debt VS Equity VS FCFNXU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 10M -10M -20M -30M

2.3 Liquidity

NXU has a Current Ratio of 1.50. This is a normal value and indicates that NXU is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.50, NXU perfoms like the industry average, outperforming 59.48% of the companies in the same industry.
NXU has a Quick Ratio of 1.50. This is a normal value and indicates that NXU is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.50, NXU belongs to the top of the industry, outperforming 83.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.5
NXU Yearly Current Assets VS Current LiabilitesNXU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 1M 2M 3M 4M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 82.16% over the past year.
Looking at the last year, NXU shows a very strong growth in Revenue. The Revenue has grown by 230.00%.
EPS 1Y (TTM)82.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.73%
Revenue 1Y (TTM)230%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-94.87%

3.2 Future

NXU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.36% yearly.
NXU is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -41.42% yearly.
EPS Next Y99.29%
EPS Next 2Y41.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

NXU Yearly Revenue VS EstimatesNXU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 100K 200K 300K 400K
NXU Yearly EPS VS EstimatesNXU Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200 -250

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NXU. In the last year negative earnings were reported.
Also next year NXU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXU Price Earnings VS Forward Price EarningsNXU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXU Per share dataNXU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80

4.3 Compensation for Growth

NXU's earnings are expected to grow with 41.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.36%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NXU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NXU INC

NASDAQ:NXU (1/21/2025, 7:44:36 PM)

After market: 0.5579 0 (-0.38%)

0.56

+0.01 (+1.82%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)N/A N/A
Inst Owners0.93%
Inst Owner Change0%
Ins Owners2.99%
Ins Owner Change-0.14%
Market Cap9.46M
Analysts45
Price TargetN/A
Short Float %39.87%
Short Ratio0.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-24.87%
Min EPS beat(2)-38.61%
Max EPS beat(2)-11.13%
EPS beat(4)1
Avg EPS beat(4)-287.55%
Min EPS beat(4)-1104.62%
Max EPS beat(4)4.15%
EPS beat(8)3
Avg EPS beat(8)-143.77%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)42%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)-100%
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 23.9
P/FCF N/A
P/OCF N/A
P/B 0.72
P/tB 0.72
EV/EBITDA N/A
EPS(TTM)-93.13
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-1
FCFYN/A
OCF(TTM)-0.86
OCFYN/A
SpS0.02
BVpS0.78
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -94.04%
ROE -154.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.03%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 255.78%
Cap/Sales 581.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.5
Altman-Z -19.57
F-Score5
WACC8.12%
ROIC/WACCN/A
Cap/Depr(3y)659.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.73%
EPS Next Y99.29%
EPS Next 2Y41.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)230%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-94.87%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year74.22%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-19.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.84%
OCF growth 3YN/A
OCF growth 5YN/A